Tech Company Financing Transactions
Navitor Pharmaceuticals Funding Round
On 1/3/2019, Navitor Pharmaceuticals raised $11.3 million in investment from private investors.
Transaction Overview
Company Name
Announced On
1/3/2019
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$11,250,003
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 12 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1030 Massachusetts Ave. 410
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Website
Email Address
Overview
New scientific insights are emerging regarding the primal signaling pathways that direct an organism's metabolic response to conditions in its environment--such as dynamic changes in the availability of nutrients, energy, oxygen and other factors--and the role of these metabolic signaling pathways in disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Hughes
Chief Medical Officer
James Owen
VP - Bus. Development
Rick Lundberg
VP - R & D
Eddine Saiah
Browse more venture capital transactions:
Prev: 1/3/2019: ZynBit venture capital transaction
Next: 1/4/2019: Mindstrong Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs